Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment

Modern Pathology(2023)10.1016/j.modpat.2023.100332Source: DataRank Database

Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment is a research paper published in Modern Pathology (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.34)OA: bronzeTopics (32)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Rui Zheng-Pywell ORCID,Chandler McLeod ORCID,Dezhi Wang ORCID,J. Mark Van Ness,Rachael Guenter ORCID

Live enrichment

PubMed:37716507 PMC:PMC10843045 OpenAlex:https://openalex.org/W4386784616

National Center for Advancing Translational Sciences

Grant: UL1TR003096

National Cancer Institute

Grant: 300006543

NCI NIH HHS

Grant: P30 CA013148

NCI NIH HHS

Grant: U54 CA118948

University of Alabama

National Institutes of Health

FWCI

1.34

Citation Percentile

0.8%

Citation Trend

2024

2025

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.modernpathology.org/article/S0893395223002375/pdf

publisherhttp://www.modernpathology.org/article/S0893395223002375/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0893395223002375?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0893395223002375?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.modpat.2023.100332

Fields of Study

Thyroid Cancer Diagnosis and TreatmentNeuroendocrine Tumor Research AdvancesPituitary Gland Disorders and Treatments

MeSH Terms

FemaleHumansMaleMiddle AgedNeoplasms, Glandular and EpithelialPrognosisReceptors, ThyrotropinThyroid NeoplasmsThyrotropinReceptors, Somatostatin

Keywords

Somatostatin receptorThyroidSomatostatin receptor 2SomatostatinSomatostatin receptor 1PathologyHormoneMedicineReceptorImmunohistochemistryHormone receptorThyroid hormone receptorInternal medicineEndocrinologyCancerBreast cancerThyroid cancerOncocytic CarcinomaThyroid-stimulating Hormone Receptor

Sustainable Development Goals

SDG 0: Good health and well-being